Resources
-
An Opportunity for Industry-Academia Partnership - Training the Next Generation of Industrial Researchers in Characterizing Higher Order Protein Structure
Case Study Bain Brenowitz Roberts 2016
-
Impact of a Formulation Change on the Higher Order Structure and Stability of a mAb
Case Study Gruia et al. 2014
-
Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It
Case Study Wei et al. 2015
-
Technical Decision-Making with Higher Order Structure Data - Starting a New Dialogue
Case Study Gabrielson Weiss 2016
-
Higher Order Structure Characterization During Protein Therapeutic Candidate Screening
Case Study Jiang et al. 2015
-
Utilization of Differential Scanning Calorimetry to Elucidate Critical Protein Structural Changes Resulting from Oxidation
Case Study Arthuer Dinh Gabrielson 2015
-
Perspectives on Higher Order Structure Characterization From the Biopharmaceutical Industry
Case Study Weiss et al. 2015
-
Specific Binding of a Nonionic Detergent Perturbs Higher Order Structure of a Therapeutic Monoclonal Antibody
Case Study Budyak Doyle Weiss 2014
-
Physicochemical In-use Studies: Industry Experts Insights
Speaker Presentation de Jong Genentech Liu Seagen 2022
-
Bringing MAM to the Next Level: Thermo Scientific MAM 2.0
Speaker Presentation Yang Hao Thermo Fisher Scientific 2022
-
Regulatory Reliance – a Future Reality for CMC?
Speaker Presentation Wilkinson Diane AstraZeneca 2022
-
mAbs to Empowered Antibodies -Strategies beyond IgG
Speaker Presentation Shapiro Marjorie CDER 2022
-
Project ORBIS: Opportunities and Challenges
from the CMC Review of Biologics at Health
Canada
Speaker Presentation Rowlandson Karen Health Canada 2022
-
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics:
A Personal Account
Speaker Presentation Rouse Jason Pfizer Inc. 2022
-
What’s in a KASA?
Knowledge-Aided Assessment and Structured Application
(KASA) For Biological Products
Speaker Presentation Roelofs Brian CDER, FDA 2022
-
The QC Response to COVID Disruption: A Case Study
Speaker Presentation Nunnally Brian Seqirus 2022
-
HTS and the Future of Vaccine Analytics
Speaker Presentation Ng Siemon Sanofi Pasteur 2022
-
Opportunities and Challenges for Decentralized Manufacturing
Speaker Presentation Moore Christine ORGANON 2022
-
Comprehensive Characterization of a Bispecific T-cell Redirector with Multiple Technologies, CE, iCIEF-MS and Novel Alternative Fragmentation
Speaker Presentation Mahan Nields Janssen 2022
-
Pioneering Disruptive Changes to the Manufacture of Biologics
Speaker Presentation Luu Minh Genentech 2022